Active Ingredient History
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Breast Neoplasms (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Ovarian Epithelial (Phase 2)
Carcinoma, Pancreatic Ductal (Phase 1)
Carcinoma, Renal Cell (Phase 1)
Carcinoma, Transitional Cell (Phase 1)
Colorectal Neoplasms (Phase 1)
Fallopian Tube Neoplasms (Phase 1)
Glioblastoma (Phase 1)
Hematologic Neoplasms (Phase 2)
Hodgkin Disease (Phase 1)
Leukemia (Phase 1)
Leukemia, Lymphoid (Phase 1)
Leukemia, Myeloid, Acute (Phase 2)
Leukemia, Myelomonocytic, Chronic (Phase 2)
Lymphoma (Phase 1)
Lymphoma, Follicular (Phase 1/Phase 2)
Lymphoma, Non-Hodgkin (Phase 1)
Melanoma (Phase 1)
Multiple Myeloma (Phase 2)
Myelodysplastic Syndromes (Phase 2)
Nasopharyngeal Neoplasms (Phase 2)
Neoplasms (Phase 2)
Osteosarcoma (Phase 1)
Ovarian Neoplasms (Phase 1)
Peritoneal Neoplasms (Phase 1)
Plasmacytoma (Phase 2)
Sarcoma (Phase 1)
Small Cell Lung Carcinoma (Phase 1)
Thyroid Neoplasms (Phase 1)
Tumor Virus Infections (Phase 1)
Urinary Bladder Neoplasms (Phase 1)
Urination Disorders (Phase 1)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue